A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
Clinical trial NCT05091567 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05091567
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2024-07-29
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.